In The News
Judge approves $180M settlement in stolen wages class action
Law firms reaped $600M from government work, with Clayton Utz the top pick
Real estate ‘mogul’ Sasha Hopkins slapped with $1.25M fine
Google faces potential class action over AdTech dominance
High Court cases could push Blue Sky class action trial to 2026
Dominique Grubisa’s companies illegally scraped court websites: OAIC
Court approves landmark $75M detention centre class action settlement
Burger ad beef between McDonald’s, Hungry Jack’s done
Bubble tea chain Chatime fined for underpaying staff
Class action probe accuses union of forcing staff to join Labor Party
Please login to bookmarkClose

An Australian law firm is investigating a class action against drug manufacturers over a commonly prescribed antibiotic said to cause “disabling” side effects, including nerve damage and psychosis.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au